Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
2nd Annual Photo Contest - Enter Here!
Ophthalmology 360
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Photo Contest
    • Industry Council
    • Advisory Board
Home > Early Onset Cataracts > Timing of secondary IOL linked to glaucoma risk but not vision in pediatric cataracts
  • Early Onset Cataracts

Timing of secondary IOL linked to glaucoma risk but not vision in pediatric cataracts

Ophthalmology 360

In children with bilateral aphakia after early-onset (before age 2) cataract surgery, secondary intraocular lens (IOLs) implantation between ages 2 and 6 results in similar visual acuity outcomes, but the risk of developing glaucoma increases significantly with later implantation age, according to a study.

The study, conducted at a single center between 2014 and 2023, followed 158 children who underwent lensectomy before the age of 2 and subsequently received secondary IOL implantation between the ages of 2 and 6. Participants were grouped by the age at which they received their secondary IOL (2 to <3 years, 3 to <4 years, 4 to <5 years, and 5 to <6 years) and monitored them through age 7.

Across the age groups, best-corrected visual acuity (BCVA) at age 7 did not differ significantly. Mean BCVA ranged from 20/62 in children implanted between ages 2 and 3, to 20/89 in those implanted between ages 5 and 6 (P = 0.20). However, the incidence of glaucoma-related complications rose with later implantation. Only 8.8% of eyes in the youngest group experienced glaucoma-related events, compared with 22.6% in the oldest group (P = 0.03).

The authors concluded that secondary IOL implantation between the ages of 2 and 6 can provide similar visual outcomes, but earlier implantation may help reduce glaucoma risk.

Reference
Hu K, Zhang Y, Chen W, et al. Visual Acuity and Complications at Age 7 Years Following Bilateral Secondary Intraocular Lens Implantation at 2 to Younger Than 6 Years for Pediatric Aphakia. JAMA Ophthalmol. 2025;doi: 10.1001/jamaophthalmol.2025.1080. Epub ahead of print. PMID: 40372731.

Share

Related Content

  • Early Onset Cataracts

Best of 2025: Surgical timing and long-term considerations in pediatric cataract care

  • Early Onset Cataracts

Quiz: Recognizing CTX in Pediatric Cataract Patients

  • Early Onset Cataracts

Oral sedation shows strong safety profile for office-based cataract surgery

  • Early Onset Cataracts

The importance of pediatric cataract surgery for a variety of patient cases

  • Early Onset Cataracts

Multifocal lenses outperform monofocal implants in pediatric cataract surgery

  • Early Onset Cataracts

When you see cataracts in pediatric patients, genetic testing is important

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Ophthalmology 360

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon